Search

Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.

… Tuesday, August 28, 2018 Nineteen aspiring scientists were celebrated this month for completing a unique summer research program offered by the Gerstner Sloan Kettering (GSK) Graduate School of Biomedical Sciences . Four of the students received special recognition for their outstanding performance and

MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.

… Wednesday, July 22, 2020 Summary MSK’s sarcoma team is focused on developing new treatments for sarcoma, a rare group of cancers that affect the body’s connective tissues. As one of the world’s most respected comprehensive centers devoted exclusively to cancer, Memorial Sloan Kettering has entire teams

Memorial Sloan Kettering launched the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.

… Tuesday, May 20, 2014 New Marie-Josée and Henry R. Kravis Center for Molecular Oncology Aims to Analyze 10,000 Patient Tumors in Its First Year Memorial Sloan Kettering Cancer Center (MSK) today launched an ambitious initiative to improve cancer care and research through genomic analysis. The new program

New research led by investigators at Memorial Sloan Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.

… Monday, July 6, 2009 New research led by investigators at Memorial Sloan Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered. The findings support the study of therapies

In our paper, published recently in the journal Expert Review of Hematology, we review the main challenges with current CD19-targeted CAR, obstacles to adopting CAR T cell therapy in solid tumors, and various strategies scientists are pursuing to overcome these issues.

… Thursday, June 11, 2020 Rapid advances in chimeric antigen receptor (CAR) T cell therapy technologies are in development and under investigation in a range of preclinical and clinical research around the globe. In our paper, published recently in the journal Expert Review of Hematology , we review the

MSK specialists are working to help reduce the stigma around lung cancer and smoking, helping to ensure that all patients get the best care.

… Thursday, April 17, 2025 More than half of people with lung cancer say they have been stigmatized by friends, family, and even healthcare providers at some point in their cancer journey. Other people may assume, because lung cancer is often caused by smoking, that the patient is to blame.  But as smoking

More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.

… Friday, April 1, 2011 Summary More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries. More than 500 people filled the Rockefeller Research Laboratories Auditorium in November 2010 for Major Trends in Modern Cancer Research.

Learn why Black women face a higher risk of death from endometrial cancer, and about a new effort led by Dr. Carol Brown at Memorial Sloan Kettering Cancer Center to close the gap.

… Friday, October 1, 2021 When Linda Collins was diagnosed with endometrial cancer in her early 60s, she wanted to find the best treatment possible. After doing her research, she felt confident she would receive the care she needed at Memorial Sloan Kettering Cancer Center. She also knew what she needed

Ralph DeBerardinis, a professor at the University of Texas Southwestern, was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.

… Monday, February 28, 2022 The Paul Marks Prize for Cancer Research was created by the Boards of Memorial Sloan Kettering Cancer Center to honor the late Paul Marks , who served as President and CEO of MSK for almost 20 years, beginning in 1980. Awarded every other year since 2001, the prize recognizes

Over the last decade radiation oncologists at Memorial Sloan Kettering have refined a technique that allows ablative doses of radiation to be delivered with low risk of toxicity to inoperable primary pancreas and liver tumors near critical organs.

… Monday, October 24, 2016 Success rates of standard treatments for inoperable primary pancreas and liver tumors are poor, but a radiotherapy technique that combines classical, modern, and novel concepts is offering renewed hope of long-term survival for these patients. Stereotactic ablative radiation